145 related articles for article (PubMed ID: 18848818)
1. A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.
Correa F; Docagne F; Mestre L; Clemente D; Hernangómez M; Loría F; Guaza C
Biochem Pharmacol; 2009 Jan; 77(1):86-100. PubMed ID: 18848818
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.
Correa F; Hernangómez-Herrero M; Mestre L; Loría F; Docagne F; Guaza C
Brain Behav Immun; 2011 May; 25(4):736-49. PubMed ID: 21310228
[TBL] [Abstract][Full Text] [Related]
3. Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB.
Correa F; Hernangómez M; Mestre L; Loría F; Spagnolo A; Docagne F; Di Marzo V; Guaza C
Glia; 2010 Jan; 58(2):135-47. PubMed ID: 19565660
[TBL] [Abstract][Full Text] [Related]
4. Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).
Correa F; Docagne F; Clemente D; Mestre L; Becker C; Guaza C
Biochem J; 2008 Feb; 409(3):761-70. PubMed ID: 17961121
[TBL] [Abstract][Full Text] [Related]
5. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB
Cruz SL; Sánchez-Miranda E; Castillo-Arellano JI; Cervantes-Villagrana RD; Ibarra-Sánchez A; González-Espinosa C
Int Immunopharmacol; 2018 Nov; 64():298-307. PubMed ID: 30243065
[TBL] [Abstract][Full Text] [Related]
6. CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
Hernangómez M; Mestre L; Correa FG; Loría F; Mecha M; Iñigo PM; Docagne F; Williams RO; Borrell J; Guaza C
Glia; 2012 Sep; 60(9):1437-50. PubMed ID: 22653796
[TBL] [Abstract][Full Text] [Related]
7. Anandamide induces cell death through lipid rafts in hepatic stellate cells.
Yang Q; Liu HY; Zhang YW; Wu WJ; Tang WX
J Gastroenterol Hepatol; 2010 May; 25(5):991-1001. PubMed ID: 20059638
[TBL] [Abstract][Full Text] [Related]
8. Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.
Malek N; Popiolek-Barczyk K; Mika J; Przewlocka B; Starowicz K
Neural Plast; 2015; 2015():130639. PubMed ID: 26090232
[TBL] [Abstract][Full Text] [Related]
9. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures.
Kreutz S; Koch M; Ghadban C; Korf HW; Dehghani F
Exp Neurol; 2007 Jan; 203(1):246-57. PubMed ID: 17010339
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: involvement of both mitochondrial and death receptor pathways.
Costa MA; Fonseca BM; Teixeira NA; Correia-da-Silva G
Placenta; 2015 Jan; 36(1):69-76. PubMed ID: 25465706
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.
Eljaschewitsch E; Witting A; Mawrin C; Lee T; Schmidt PM; Wolf S; Hoertnagl H; Raine CS; Schneider-Stock R; Nitsch R; Ullrich O
Neuron; 2006 Jan; 49(1):67-79. PubMed ID: 16387640
[TBL] [Abstract][Full Text] [Related]
13. Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis.
Ortega-Gutiérrez S; Molina-Holgado E; Arévalo-Martín A; Correa F; Viso A; López-Rodríguez ML; Di Marzo V; Guaza C
FASEB J; 2005 Aug; 19(10):1338-40. PubMed ID: 15941768
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts.
Abidi AH; Presley CS; Dabbous M; Tipton DA; Mustafa SM; Moore BM
Arch Oral Biol; 2018 Mar; 87():79-85. PubMed ID: 29274621
[TBL] [Abstract][Full Text] [Related]
15. Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling.
Soliman E; Van Dross R
Mol Carcinog; 2016 Nov; 55(11):1807-1821. PubMed ID: 26513129
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids drive the acquisition of an alternative phenotype in microglia.
Mecha M; Feliú A; Carrillo-Salinas FJ; Rueda-Zubiaurre A; Ortega-Gutiérrez S; de Sola RG; Guaza C
Brain Behav Immun; 2015 Oct; 49():233-45. PubMed ID: 26086345
[TBL] [Abstract][Full Text] [Related]
17. Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis.
Szilagyi JT; Composto-Wahler GM; Joseph LB; Wang B; Rosen T; Laskin JD; Aleksunes LM
Pharmacol Res; 2019 Mar; 141():331-342. PubMed ID: 30610963
[TBL] [Abstract][Full Text] [Related]
18. Endogenous cannabinoid anandamide impairs cell growth and induces apoptosis in chondrocytes.
Gómez R; Conde J; Scotece M; López V; Lago F; Gómez Reino JJ; Gualillo O
J Orthop Res; 2014 Sep; 32(9):1137-46. PubMed ID: 24902823
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid type-2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL-1β stimulated primary human periodontal ligament fibroblasts.
Abidi AH; Alghamdi SS; Dabbous MK; Tipton DA; Mustafa SM; Moore BM
J Periodontal Res; 2020 Oct; 55(5):762-783. PubMed ID: 32562275
[TBL] [Abstract][Full Text] [Related]
20. A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist.
Snider NT; Nast JA; Tesmer LA; Hollenberg PF
Mol Pharmacol; 2009 Apr; 75(4):965-72. PubMed ID: 19171674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
